Identification of dual PPARα/γ agonists and their effects on lipid metabolism
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (24) , 7676-7684
Abstract
No abstract availableKeywords
Funding Information
- Faculty of Pharmacy
- University of Sydney (U1758, U7007)
- NHMRC
This publication has 52 references indexed in Scilit:
- Inhibition of Mitogen-Activated Protein Kinase Erk1/2 Promotes Protein Degradation of ATP Binding Cassette Transporters A1 and G1 in CHO and HuH7 CellsPLOS ONE, 2013
- Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ ReceptorsPLOS ONE, 2012
- Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping ApproachPLOS ONE, 2012
- Protocol for effective differentiation of 3T3-L1 cells to adipocytesAnalytical Biochemistry, 2012
- Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?Cardiovascular Diabetology, 2012
- FenofibrateDrugs, 2011
- Diabetes area participation analysis: a review of companies and targets described in the 2008 – 2010 patent literatureExpert Opinion on Therapeutic Patents, 2010
- Modified coumarins. 29. Synthesis of structural analogs of natural 6-arylfuro[3,2-g]chromen-7-onesChemistry of Natural Compounds, 2009
- Structure–activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2Bioorganic & Medicinal Chemistry, 2007
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994